CHMP4C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.129600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.740200E-01
Normal-vs-Stage2
1.875400E-01
Normal-vs-Stage3
6.847600E-01
Normal-vs-Stage4
1.914590E-01
Stage1-vs-Stage2
8.179600E-01
Stage1-vs-Stage3
6.006400E-01
Stage1-vs-Stage4
5.193000E-01
Stage2-vs-Stage3
5.256400E-01
Stage2-vs-Stage4
2.724800E-01
Stage3-vs-Stage4
4.361200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.471200E-01
Normal-vs-AfricanAmerican
1.796160E-01
Normal-vs-Asian
1.288970E-01
Caucasian-vs-AfricanAmerican
5.676000E-01
Caucasian-vs-Asian
2.638200E-01
AfricanAmerican-vs-Asian
8.250400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.803430E-01
Normal-vs-Female
2.785600E-01
Male-vs-Female
2.807200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.874600E-01
Normal-vs-Age(41-60Yrs)
1.977590E-01
Normal-vs-Age(61-80Yrs)
2.467800E-01
Normal-vs-Age(81-100Yrs)
1.506550E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.149800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.896600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.051800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.096600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.867400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.738600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.049600E-01
Normal-vs-Daily Drinker
2.815200E-01
Normal-vs-Weekly Drinker
3.927600E-01
Normal-vs-Occasional Drinker
4.937700E-02
Normal-vs-Social Drinker
2.963000E-01
Non Drinker-vs-Daily Drinker
6.500000E-01
Non Drinker-vs-Weekly Drinker
8.274000E-01
Non Drinker-vs-Occasional Drinker
1.561960E-01
Non Drinker-vs-Social Drinker
1.345780E-01
Daily Drinker-vs-Weekly Drinker
6.222800E-01
Daily Drinker-vs-Occasional Drinker
4.945400E-01
Daily Drinker-vs-Social Drinker
1.341820E-01
Weekly Drinker-vs-Occasional Drinker
2.142600E-01
Weekly Drinker-vs-Social Drinker
4.619200E-01
Occasional Drinker-vs-Social Drinker
7.964900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.891800E-02
Normal-vs-Grade 2
2.138200E-02
Normal-vs-Grade 3
5.284500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.802400E-02
Grade 1-vs-Grade 3
3.936500E-03
Grade 1-vs-Grade 4
7.891800E-02
Grade 2-vs-Grade 3
2.501600E-01
Grade 2-vs-Grade 4
2.138200E-02
Grade 3-vs-Grade 4
5.284500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.002200E-01
Normal-vs-NonDiabetic
1.921420E-01
Diabetic-vs-NonDiabetic
8.683600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.692620E-01
Normal-vs-NoPancreatitis
2.267600E-01
Pancreatitis-vs-NoPancreatitis
3.410800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.548020E-01
Normal-vs-N1
2.165400E-01
N0-vs-N1
9.219200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.021540E-02
Normal-vs-TP53-NonMutant
2.607800E-01
TP53-Mutant-vs-TP53-NonMutant
1.8918000055379E-08
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
